Plain-English translation of NCT07379333 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called , given as a weekly injection under the skin, for people with type 2 diabetes whose blood sugar remains too high even while taking metformin and dapagliflozin. The study will compare this medication to a placebo (a fake injection with no active drug) to see if it works better at lowering blood sugar and is safe to use.
Many people with type 2 diabetes find that their current medications aren't enough to control their blood sugar. Researchers want to see if this new treatment can help people achieve better diabetes control and improve their overall health.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the new medication or a placebo as a weekly injection under your skin. You'll attend multiple visits at the research clinic to have your blood sugar monitored, answer questions about your health, and discuss how you're feeling. The study will last several months, and you'll need to keep taking your current diabetes medications and follow recommended diet and exercise habits throughout your participation.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
South Korea